Indication: First-line chemotherapy for metastatic ovarian cancer after initial or subsequent chemotherapy failure. Metastatic breast cancer after combined chemotherapy failure or recurrence within 6 months of adjuvant chemotherapy, first-line treatment for advanced non-small cell lung cancer, and adjuvant therapy after surgery for lymph node-positive breast cancer.

Indication: First-line chemotherapy for metastatic ovarian cancer after initial or subsequent chemotherapy failure. Metastatic breast cancer after combined chemotherapy failure or recurrence within 6 months of adjuvant chemotherapy, first-line treatment for advanced non-small cell lung cancer, and adjuvant therapy after surgery for lymph node-positive breast cancer.

Indication: It is mainly used for ovarian cancer, small cell lung cancer, non-small cell lung cancer, head and neck squamous cell carcinoma, esophageal cancer, seminoma, bladder cancer, mesothelioma, etc.

Indication: It is mainly used for ovarian cancer, small cell lung cancer, non-small cell lung cancer, head and neck squamous cell carcinoma, esophageal cancer, seminoma, bladder cancer, mesothelioma, etc.

Indication: It is mainly used to treat advanced breast cancer, ovarian cancer, non-small cell lung cancer, head and neck cancer, and small cell lung cancer; it also has certain effects on gastric cancer, pancreatic cancer, melanoma, etc.

Indication: It is suitable for the treatment of patients with B-cell chronic lymphocytic leukemia (CLL) who have received at least one standard alkylating agent regimen, but whose condition has not improved or continues to progress during or after treatment. Reference: It is used for the treatment of B-cell chronic lymphocytic leukemia (CLL), and is suitable for patients whose condition has not responded to a standard dosing regimen containing alkylating agents or whose condition has worsened, with an overall effective rate of 32% to 48%. Fudahua Tablets (Fludarabine Phosphate Tablets) can also be used to treat leukemia and lymphoma, but it is not effective for solid tumors such as breast cancer, colon cancer, non-small cell lung cancer, and head and neck cancer.

Indication: It is effective against malignant tumors such as non-small cell lung cancer, small cell lung cancer, malignant lymphoma, breast cancer, esophageal cancer and malignant melanoma.

Indication: It is effective against malignant tumors such as non-small cell lung cancer, small cell lung cancer, malignant lymphoma, breast cancer, esophageal cancer and malignant melanoma.

Indication: It is effective against malignant tumors such as non-small cell lung cancer, small cell lung cancer, malignant lymphoma, breast cancer, esophageal cancer and malignant melanoma.

Indication: It is effective against malignant tumors such as non-small cell lung cancer, small cell lung cancer, malignant lymphoma, breast cancer, esophageal cancer and malignant melanoma.